Display options
Share it on

Toxicol Res. 2020 Feb 07;36(3):257-266. doi: 10.1007/s43188-019-00029-x. eCollection 2020 Jul.

Factors associated with outcomes in organophosphate and carbamate poisoning: a retrospective study.

Toxicological research

B Shrikar Reddy, Teny Grace Skaria, Sravani Polepalli, Sudha Vidyasagar, Mahadev Rao, Vijayanarayana Kunhikatta, Sreedharan Nair, Girish Thunga

Affiliations

  1. Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104 India.
  2. Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

PMID: 32685430 PMCID: PMC7351927 DOI: 10.1007/s43188-019-00029-x

Abstract

Organophosphate and carbamate (OPC) poisoning is a major global health hazard requiring immediate medical intervention. Atropine (ATR) is an essential antidote in organophosphate and carbamate poisoning, with the inclusion of cholinesterase reactivators and other anticholinergics, namely pralidoxime (PAM) and glycopyrrolate (GPR). This study aimed to compare the efficacy of various treatment regimens and identify the factors affecting mortality. The data of patients presented at the emergency unit with the consumption of OPC compounds between the years 2013 and 2017 were retrospectively reviewed. The study population was then categorized into four treatment patterns (1) ATR alone, (2) ATR and PAM, (3) ATR and GPR, (4) ATR, PAM and GPR. The outcome of the patients was assessed in terms of survival, intubation, ICU days, and days of ventilation and hospitalization. Univariate and multivariate analyses were performed to investigate the risk factors associated with mortality and odds ratio (OR). A total of 441 patients were included in the study, of which 69.16% were males, and 375 patients survived. Consumption of poison with a suicidal intention was reported in 98.19% of the patients, and the treatment with ATR and PAM (42.86%) was observed to have lower days of ventilation in comparison to the treatment with ATR and GPR (

© Korean Society of Toxicology 2020.

Keywords: Atropine; Carbamate; Glycopyrrolate; Older age; Organophosphate; Pralidoxime

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interests.

References

  1. Toxicol Lett. 2009 Oct 28;190(2):107-15 - PubMed
  2. Toxicol Ind Health. 2014 Jun;30(5):421-5 - PubMed
  3. BMC Public Health. 2007 Dec 21;7:357 - PubMed
  4. Saudi J Anaesth. 2015 Jan;9(1):49-54 - PubMed
  5. Environ Health Perspect. 2005 Sep;113(9):1243-9 - PubMed
  6. Value Health. 2014 Nov;17(7):A750-1 - PubMed
  7. J Postgrad Med. 2014 Jan-Mar;60(1):27-30 - PubMed
  8. Can J Anaesth. 1998 Apr;45(4):337-40 - PubMed
  9. Lancet. 2006 Dec 23;368(9554):2231-42 - PubMed
  10. Anaesthesia. 1983 Dec;38(12):1195-204 - PubMed
  11. Hum Exp Toxicol. 2006 Mar;25(3):157-62 - PubMed
  12. Ann Gen Psychiatry. 2006 Nov 21;5:17 - PubMed
  13. Lancet. 2008 Feb 16;371(9612):597-607 - PubMed
  14. Lancet. 2006 Dec 16;368(9553):2136-41 - PubMed
  15. Indian J Anaesth. 2014 Jan;58(1):11-7 - PubMed
  16. Hum Exp Toxicol. 1997 Aug;16(8):466-72 - PubMed
  17. J Forensic Leg Med. 2017 Apr;47:29-34 - PubMed
  18. Neurol India. 2000 Dec;48(4):308-13 - PubMed
  19. Br J Anaesth. 1989 Dec;63(6):736-50 - PubMed
  20. J Toxicol Clin Toxicol. 1991;29(1):81-90 - PubMed
  21. QJM. 2006 Aug;99(8):513-22 - PubMed
  22. Hum Exp Toxicol. 2009 Nov;28(11):715-20 - PubMed
  23. Niger J Clin Pract. 2015 Sep-Oct;18(5):644-50 - PubMed
  24. S Afr Med J. 1987 Nov 7;72(9):593-7 - PubMed
  25. J Toxicol Clin Toxicol. 2004;42(6):865-75 - PubMed
  26. Am J Emerg Med. 2009 Nov;27(9):1117-24 - PubMed
  27. Hum Exp Toxicol. 2001 Jan;20(1):15-8 - PubMed
  28. Ann Afr Med. 2014 Apr-Jun;13(2):71-5 - PubMed
  29. BMJ. 2007 Mar 24;334(7594):629-34 - PubMed
  30. Br J Clin Pharmacol. 2009 Dec;68(6):916-9 - PubMed
  31. Toxicol Rev. 2003;22(3):165-90 - PubMed
  32. N Am J Med Sci. 2015 Jun;7(6):259-65 - PubMed
  33. Am J Emerg Med. 1990 Jan;8(1):68-70 - PubMed
  34. Ann Emerg Med. 2011 Dec;58(6):559-564.e6 - PubMed
  35. Toxicol Int. 2013 Sep;20(3):214-7 - PubMed

Publication Types